Effect of Safinamide on Sleep Quality in Patients With Parkinson's Disease
NCT03968744
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
11
Enrollment
OTHER
Sponsor class
Stopped
insufficient eligible patients for enrollment
Conditions
Idiopathic Parkinson's Disease (at Later Stage)
Interventions
DRUG:
Safinamide
Sponsor
Alain Kaelin
Collaborators
[object Object]